Basis: Latest reported fiscal year. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on assets (ROA) high or low?
The return on assets (ROA) of -2.39% is 164% below its 5-year average of 3.75%, near the low end of its 5-year range (-2.39%–6.63%).
As of the fiscal period ended Saturday, December 27, 2025. 154.26% below its 12-month average of -0.94%.
Annual fiscal-year return on assets; no daily interpolation.
RETURN ON ASSETS (ROA)
-2.39%
RETURN ON ASSETS (ROA) AVG TTM
-0.94%
RETURN ON ASSETS (ROA) AVG 3Y
2.58%
RETURN ON ASSETS (ROA) AVG 5Y
3.75%
RETURN ON ASSETS (ROA) AVG 10Y
4.63%
RETURN ON ASSETS (ROA) AVG 15Y
6.07%
RETURN ON ASSETS (ROA) AVG 20Y
5.95%
CURRENT VS TTM AVG
-154.26%
CURRENT VS 3Y AVG
-192.73%
CURRENT VS 5Y AVG
-163.71%
CURRENT VS 10Y AVG
-151.66%
CURRENT VS 15Y AVG
-139.38%
CURRENT VS 20Y AVG
-140.18%
SECTOR MEDIAN · HEALTHCARE
4.93%
median of 79 covered companies
CURRENT VS SECTOR MEDIAN
-148.48%
vs the sector median at left
Charles River Laboratories International, Inc.
Market Cap
$10.91B
Return on Assets (ROA)
-2.39%
TTM Avg
-0.94%
3Y Avg
2.58%
5Y Avg
3.75%
Market Cap
$11.21B
Return on Assets (ROA)
4.30%
TTM Avg
4.54%
3Y Avg
7.94%
5Y Avg
8.21%
Market Cap
$11.31B
Return on Assets (ROA)
10.14%
TTM Avg
10.65%
3Y Avg
7.37%
5Y Avg
5.11%
Market Cap
$10.37B
Return on Assets (ROA)
-9.07%
TTM Avg
-6.92%
3Y Avg
-1.48%
5Y Avg
0.07%
Market Cap
$10.31B
Return on Assets (ROA)
-0.04%
TTM Avg
5.29%
3Y Avg
6.08%
5Y Avg
6.13%
Market Cap
$11.57B
Return on Assets (ROA)
-5.53%
TTM Avg
-3.64%
3Y Avg
-1.62%
5Y Avg
0.47%
Market Cap
$11.96B
Return on Assets (ROA)
6.81%
TTM Avg
6.68%
3Y Avg
6.69%
5Y Avg
12.75%
Market Cap
$9.75B
Return on Assets (ROA)
9.70%
TTM Avg
8.61%
3Y Avg
6.84%
5Y Avg
6.99%
Market Cap
$9.74B
Return on Assets (ROA)
3.49%
TTM Avg
3.68%
3Y Avg
4.39%
5Y Avg
5.01%
| NAME | MARKET CAP | RETURN ON ASSETS (ROA) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Charles River Laboratories International, Inc. (CRL) | $10.91B | -2.39% | -0.94% | 2.58% | 3.75% |
| Bio-Techne Corporation (TECH)vs › | $11.21B | 4.30% | 4.54% | 7.94% | 8.21% |
| Insulet Corp. (PODD)vs › | $11.31B | 10.14% | 10.65% | 7.37% | 5.11% |
| Walgreens Boots Alliance, Inc. (WBA)vs › | $10.37B | -9.07% | -6.92% | -1.48% | 0.07% |
| Molina Healthcare, Inc. (MOH)vs › | $10.31B | -0.04% | 5.29% | 6.08% | 6.13% |
| Baxter International Inc. (BAX)vs › | $11.57B | -5.53% | -3.64% | -1.62% | 0.47% |
| Align Technology, Inc. (ALGN)vs › | $11.96B | 6.81% | 6.68% | 6.69% | 12.75% |
| Universal Health Services, Inc. (UHS)vs › | $9.75B | 9.70% | 8.61% | 6.84% | 6.99% |
| Henry Schein, Inc. (HSIC)vs › | $9.74B | 3.49% | 3.68% | 4.39% | 5.01% |
| Revvity, Inc. (RVTY)vs › | $12.32B | 2.01% | 2.19% | 1.89% | 3.83% |
ROA
-2.4%
ROE
-6.3%
ROA = Net Income / Total Assets
Return on assets measures how efficiently a company generates profit from its total assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON ASSETS (ROA) |
|---|---|
| 2025-12-27 | -2.02% |
| 2024-12-28 | 0.14% |
| 2023-12-31 | 5.79% |
| 2022-12-31 | 6.40% |
| 2021-12-31 | 5.57% |
| 2020-12-31 | 6.63% |
| 2019-12-31 | 5.37% |
| 2018-12-31 | 5.87% |
| 2017-12-31 | 4.21% |
| 2016-12-31 | 5.71% |
| 2015-12-31 | 7.22% |
| 2014-12-31 | 6.72% |
| 2013-12-31 | 6.25% |
| 2012-12-31 | 6.13% |
| 2011-12-31 | 7.03% |
| 2010-12-31 | -19.42% |
| 2009-12-31 | 5.19% |
| 2008-12-31 | -24.16% |
| 2007-12-31 | 5.50% |
| 2006-12-31 | -2.18% |
| 2005-12-31 | 5.59% |
| 2004-12-31 | 3.42% |
| 2003-12-31 | 10.02% |
| 2002-12-31 | 7.15% |
| 2001-12-31 | 6.20% |
| 2000-12-31 | -2.73% |
| 1999-12-31 | 4.72% |
| 1998-12-31 | 9.98% |
